文献速递垂体与肾上腺疾病性腺与生殖内分泌

液相色谱与放射免疫分析法在先天性肾上腺增生新生儿筛查假阳性下降中的效能

Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives' Drop-off in CAH Newborn Screening.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

结果显示LC-MS/MS法阳性预测值更高(49% vs 30%),且17-OHP/LC-MS/MS诊断性能最佳( cutoff 48.3 ng/mL,灵敏度100%),(17-OHP+Δ4)/皮质醇比值具有最高鉴别能力( cutoff 24.9,阳性预测值100%)。

要点

  • LC-MS/MS法检测血清17-OHP较RIA法提高阳性预测值(49% vs 30%)。
  • 17-OHP/LC-MS/MS诊断性能最佳, cutoff 48.3 ng/mL时灵敏度100%。
  • (17-OHP+Δ4)/皮质醇比值鉴别能力最高, cutoff 24.9时阳性预测值100%。

核心结论

  • LC-MS/MS法检测血清17-OHP为最佳确认试验,可辅以(17-OHP+Δ4)/皮质醇比值分析。
  • 基因分型主要用于解决持续不确定的生化结果。

研究设计与样本

  • 对新生儿17-OHP结果≥2倍99.5百分位者召回,进行血清RIA和LC-MS/MS检测及基因分型。

主要发现

  • 新生儿17-OHP初筛召回率为0.03%。
  • 血清17-OHP水平持续升高者中,RIA法占26%,LC-MS/MS法占11%。
  • RIA法和LC-MS/MS法的阳性预测值分别为30%和49%。

关键数值与推荐

  • 17-OHP/LC-MS/MS的cutoff为48.3 ng/mL(146.3 nmol/L)时灵敏度100%。
  • (17-OHP+Δ4)/皮质醇比值的cutoff为24.9时阳性预测值100%。
  • 血清21-脱氧皮质醇(21DF)性能良好,特异性99%,与LC-MS/MS法测17-OHP相当。

临床怎么用

  • 在先天性肾上腺增生新生儿筛查的确认阶段,优先采用LC-MS/MS法检测血清17-OHP。
  • 可结合(17-OHP+Δ4)/皮质醇比值提高鉴别诊断能力。
  • 对生化结果持续不确定者可行CYP21A2基因分型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The main challenge in congenital adrenal hyperplasia newborn screening (NBS) is the high rate of false-positive results, emphasizing the need for specific serum confirmatory tests. Data on the effectiveness of serum 17-hydroxyprogesterone (17OHP) measurements using available methodologies remain limited. OBJECTIVES: To evaluate the efficacy of confirmatory tests using measurements of serum steroids by radioimmunoassay (RIA) and liquid chromatography tandem mass spectrometry (LC-MS/MS) methodologies. DESIGN AND SETTING: A prospective longitudinal cohort study. PATIENTS: Data of 708 437 newborns (NBs) were evaluated. METHODS: Neonatal-17OHP (N17OHP) results ≥ 2 × 99.5th were recalled for serum dosages by RIA (17OHP), by LC-MS/MS (17OHP, 21-deoxycortisol-21DF, androstenedione-Δ4, and cortisol) and positive predictive values (PPV) were determined. Altered hormonal results were submitted to CYP21A2 genotyping. Nonparametric tests and receiver operating characteristic (ROC)-curves were used. RESULTS: Recall rate of N17OHP (first tier) was 0.03% and serum 17OHP levels remained increased in 26% (RIA) and 11% (LC-MS/MS) of NBs, yielding PPV of 30% and 49%, respectively. Fifty-eight NBs were diagnosed with classical forms, and 32 asymptomatic NBs persisted with increased serum 17OHP levels. ROC-curves between false and true-positive tests disclosed highest diagnostic performance for 17OHP/LC-MS/MS [cutoff 48.3 ng/mL (146.3 nmol/L) = 100%-sensitivity]. The (17OHP+Δ4)/cortisol ratio presented the highest discriminative ability (cutoff 24.9 = 100%-PPV); serum 21DF presented a good performance and was comparable to 17OHP measured by LC-MS/MS (99%-specificity). CONCLUSION: Measurement of 17OHP by LC-MS/MS provides the best performance for serum confirmatory tests and may be complemented by the (17OHP+Δ4)/cortisol ratio analysis. Genotyping is useful mainly to resolve persistently indeterminate biochemical results.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Carvalho DF, Lima-Valassi HP, Hayashi GY, et al. Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives' Drop-off in CAH Newborn Screening. J Clin Endocrinol Metab. 2026. PMID: 41811754. doi:10.1210/clinem/dgag107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。